Heres a situation every somatotropic researcher eventually runs into: three compounds on the shelf, all of them secretagogues, all hitting GHSR-1a and the protocol decision matters more than most people initially realize
Our IV therapies are provided by certified medical professionals and are available 24/7
Integrated bioinformatics and machine learning reveal pan-apoptosis and immune infiltration signatures in diabetic nephropathy
The activation is linked to the generation of vasoconstrictive agents, including MCP-1, (pro)renin receptor, endothelin, and angiotensin II, while concomitantly diminishing vasodilatory compounds like nitric oxide, which may contribute to the development of hypertension and lead to decreased viability of cardiomyocytes and myocardial damage
You can find more in-depth information on our Peptide Intelligence page to guide your research
GHRH analogs These act through the GHRH receptor: CJC-1295 with DAC CJC-1295 No DAC / Modified GRF (1-29) Sermorelin Tesamorelin Native GHRH / GRF fragments GHRPs and ghrelin mimetics These act through the growth hormone secretagogue receptor pathway: Ipamorelin GHRP-2 GHRP-6 Hexarelin Alexamorelin / GHRP-1 MK-677 / Ibutamoren, though this is non-peptide This section is useful for SEO because it expands the article beyond a narrow three-way comparison and establishes topical authority around the broader GH secretagogue category